Esbriet European Union - English - EMA (European Medicines Agency)

esbriet

roche registration gmbh - pirfenidone - idiopathic pulmonary fibrosis; lung diseases; respiratory tract diseases - immunosuppressants - esbriet is indicated in adults for the treatment of idiopathic pulmonary fibrosis.

ESBRIET 267 MG Israel - English - Ministry of Health

esbriet 267 mg

roche pharmaceuticals (israel) ltd - pirfenidone - hard capsule - pirfenidone 267 mg - pirfenidone - esbriet is indicated in adults for the treatment of mild to moderate idiopathic pulmonary fibrosis (ipf).27/01/2019 בקשה לתוספת התויה renal impairment no dose adjustment is necessary in patients with mild to moderate renal impairment. esbriet should be used with caution in patients with moderate (crcl 30-50 ml/min) renal impairment.

ESBRIET 267 MG Israel - English - Ministry of Health

esbriet 267 mg

roche pharmaceuticals (israel) ltd - pirfenidone - hard capsule - pirfenidone 267 mg - pirfenidone - esbriet is indicated in adults for the treatment of mild to moderate idiopathic pulmonary fibrosis (ipf).27/01/2019 בקשה לתוספת התויה renal impairment no dose adjustment is necessary in patients with mild to moderate renal impairment. esbriet should be used with caution in patients with moderate (crcl 30-50 ml/min) renal impairment.

ESBRIET 267 MG TABLETS Israel - English - Ministry of Health

esbriet 267 mg tablets

roche pharmaceuticals (israel) ltd - pirfenidone - film coated tablets - pirfenidone 267 mg - pirfenidone - esbriet is indicated in adults for the treatment of mild to moderate idiopathic pulmonary fibrosis (ipf).

ESBRIET 801 MG TABLETS Israel - English - Ministry of Health

esbriet 801 mg tablets

roche pharmaceuticals (israel) ltd - pirfenidone - film coated tablets - pirfenidone 801 mg - pirfenidone - esbriet is indicated in adults for the treatment of mild to moderate idiopathic pulmonary fibrosis (ipf)..